Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,219 | 67,058,230 | -0.55% | 0.10% | 3.55% | 18.70% | 3.30% | 15.73% |
| Healthcare | HEALTHCARE | Sector | 1,190 | 6,006,589 | -1.95% | -1.42% | -1.40% | 0.44% | -6.24% | -9.81% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 615 | 2,906,508 | -2.40% | -0.38% | -0.59% | 2.30% | 1.01% | -13.53% |
Show
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Medicine, Inc. | PRME:USAPRME:USA | Stock | 1 | 563 | -10.72% | 4.63% | 193.84% | 222.56% | 54.87% | -24.87% |
| Cidara Therapeutics, Inc. | CDTX:USACDTX:USA | Stock | 1 | 629 | -6.91% | 2.07% | 112.26% | 174.79% | 143.02% | 348.56% |
| Verve Therapeutics, Inc. | VERV:USAVERV:USA | Stock | 1 | 979 | -0.09% | -0.99% | 74.37% | 167.48% | 100.36% | 63.74% |
| Sana Biotechnology, Inc. | SANA:USASANA:USA | Stock | 1 | 942 | -0.95% | 7.46% | 64.57% | 130.94% | 20.81% | -29.75% |
| Cogent Biosciences, Inc. | COGT:USACOGT:USA | Stock | 1 | 1,309 | 3.70% | 17.59% | 59.28% | 151.09% | 51.92% | 24.06% |
| Amylyx Pharmaceuticals, Inc. | AMLX:USAAMLX:USA | Stock | 1 | 723 | -3.45% | 16.33% | 47.10% | 108.21% | 155.35% | 275.93% |
| Rhythm Pharmaceuticals, Inc. | RYTM:USARYTM:USA | Stock | 1 | 5,674 | 0.24% | 37.18% | 41.80% | 48.59% | 62.80% | 78.65% |
| SAGE Therapeutics, Inc. | SAGE:USASAGE:USA | Stock | 1 | 573 | 0.22% | 0.11% | 38.94% | 23.92% | 22.27% | -22.02% |
| Intellia Therapeutics, Inc. | NTLA:USANTLA:USA | Stock | 1 | 1,189 | -3.93% | 3.24% | 37.49% | 53.07% | 14.23% | -55.49% |
| Zevra Therapeutics, Inc. | ZVRA:USAZVRA:USA | Stock | 1 | 699 | 0.00% | 10.74% | 36.50% | 83.24% | 58.68% | 118.63% |
| Pharvaris NV | PHVS:USAPHVS:USA | Stock | 1 | 1,253 | -3.40% | 27.86% | 33.43% | 82.17% | 40.10% | 22.48% |
| Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 928 | -5.31% | 6.67% | 32.24% | 23.24% | 3.03% | 101.67% |
| Meiragtx Holdings plc | MGTX:USAMGTX:USA | Stock | 1 | 681 | -3.60% | 6.20% | 30.05% | 56.39% | 45.01% | 85.90% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 525 | -1.71% | 13.95% | 29.08% | 46.14% | 2.93% | -43.98% |
| CRISPR Therapeutics AG | CRSP:USACRSP:USA | Stock | 1 | 4,554 | -6.54% | -3.81% | 27.74% | 35.87% | 35.73% | -8.93% |
| UroGen Pharma Ltd. | URGN:USAURGN:USA | Stock | 1 | 647 | -3.11% | 2.41% | 26.71% | 32.45% | 37.92% | -17.07% |
| Replimune Group, Inc. | REPL:USAREPL:USA | Stock | 1 | 956 | 9.93% | 32.76% | 25.44% | 65.11% | 13.87% | 19.69% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 992 | -3.03% | 10.50% | 24.63% | 75.91% | 91.50% | 33.36% |
| Metsera, Inc. | MTSR:USAMTSR:USA | Stock | 1 | 4,507 | 1.20% | 42.70% | 24.29% | 136.41% | N/A | N/A |
| Ocular Therapeutix, Inc. | OCUL:USAOCUL:USA | Stock | 1 | 1,766 | -1.60% | 11.79% | 23.91% | 46.50% | 36.58% | 36.41% |
| ARS Pharmaceuticals, Inc. | SPRY:USASPRY:USA | Stock | 1 | 1,723 | -1.90% | 3.60% | 21.94% | 21.35% | 55.95% | 54.71% |
| ATAI Life Sciences NV | ATAI:USAATAI:USA | Stock | 1 | 529 | -2.57% | 0.76% | 21.56% | 92.03% | 86.62% | 72.08% |
| Ardelyx, Inc. | ARDX:USAARDX:USA | Stock | 1 | 1,076 | -2.39% | 0.45% | 20.97% | -1.53% | -23.47% | -23.60% |
| Summit Therapeutics, Inc. | SMMT:USASMMT:USA | Stock | 1 | 18,066 | -4.09% | 5.96% | 20.83% | -6.77% | 34.03% | 184.91% |
| Xeris Biopharma Holdings, Inc. | XERS:USAXERS:USA | Stock | 1 | 825 | -2.76% | 10.90% | 19.68% | 27.16% | 61.28% | 124.63% |
| BridgeBio Pharma, Inc. | BBIO:USABBIO:USA | Stock | 1 | 8,915 | -1.52% | 8.74% | 18.45% | 34.76% | 39.24% | 73.17% |
| Maze Therapeutics, Inc. | MAZE:USAMAZE:USA | Stock | 1 | 701 | 1.72% | 6.31% | 18.15% | 88.35% | N/A | N/A |
| Ionis Pharmaceuticals, Inc. | IONS:USAIONS:USA | Stock | 1 | 6,680 | -1.29% | 1.60% | 17.91% | 46.44% | 20.21% | -12.50% |
| Nuvation Bio, Inc. | NUVB:USANUVB:USA | Stock | 1 | 724 | -0.47% | 3.90% | 17.68% | 5.45% | -20.22% | -38.44% |
| Bausch Health Cos., Inc. | BHC:USABHC:USA | Stock | 1 | 2,372 | 1.26% | -4.18% | 16.52% | 47.93% | -13.24% | -13.48% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 3,677 | 0.44% | 13.20% | 16.33% | 33.98% | -9.01% | 325.93% |
| KalVista Pharmaceuticals, Inc. | KALV:USAKALV:USA | Stock | 1 | 755 | -0.33% | 1.47% | 15.89% | 26.95% | 101.73% | 16.33% |
| Moderna, Inc. | MRNA:USAMRNA:USA | Stock | 1 | 12,221 | -3.92% | -2.95% | 15.47% | 17.84% | -10.16% | -74.00% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 1,056 | -3.19% | 10.97% | 15.23% | 74.42% | -18.95% | 1.99% |
| Cytokinetics, Inc. | CYTK:USACYTK:USA | Stock | 1 | 4,532 | -1.48% | 10.98% | 14.49% | -4.52% | -18.63% | -32.10% |
| Arcutis Biotherapeutics, Inc. | ARQT:USAARQT:USA | Stock | 1 | 1,835 | -3.14% | 11.92% | 14.07% | 19.01% | 12.99% | 45.01% |
| AnaptysBio, Inc. | ANAB:USAANAB:USA | Stock | 1 | 809 | -1.19% | 9.81% | 13.75% | 49.10% | 82.15% | -11.53% |
| Agios Pharmaceuticals, Inc. | AGIO:USAAGIO:USA | Stock | 1 | 2,269 | -0.10% | 8.02% | 13.59% | 42.41% | 14.26% | -14.58% |
| Oric Pharmaceuticals, Inc. | ORIC:USAORIC:USA | Stock | 1 | 780 | 1.20% | 5.27% | 13.55% | 114.87% | 27.67% | 9.15% |
| MoonLake Immunotherapeutics | MLTX:USAMLTX:USA | Stock | 1 | 3,153 | -2.34% | 6.25% | 12.84% | 38.94% | 9.76% | 7.05% |
| Beam Therapeutics, Inc. | BEAM:USABEAM:USA | Stock | 1 | 1,969 | -7.51% | -3.55% | 12.27% | 15.18% | -23.34% | -27.16% |
| Trevi Therapeutics, Inc. | TRVI:USATRVI:USA | Stock | 1 | 685 | -2.14% | 17.16% | 11.18% | 15.29% | 71.93% | 145.00% |
| EyePoint Pharmaceuticals, Inc. | EYPT:USAEYPT:USA | Stock | 1 | 677 | -3.24% | -1.11% | 11.06% | 72.33% | 26.97% | -4.74% |
| Oruka Therapeutics, Inc. | ORKA:USAORKA:USA | Stock | 1 | 534 | -3.06% | 6.42% | 10.72% | 75.06% | 1.60% | -34.09% |
| LENZ Therapeutics, Inc. | LENZ:USALENZ:USA | Stock | 1 | 902 | -2.91% | 4.43% | 10.72% | 40.92% | 41.16% | 55.73% |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 609 | -3.12% | 8.03% | 10.55% | 45.41% | 24.25% | 8.18% |
| Bausch + Lomb Corp. | BLCO:USABLCO:USA | Stock | 1 | 4,845 | 0.22% | -2.07% | 10.21% | 11.92% | -21.07% | -13.99% |
| Enliven Therapeutics, Inc. | ELVN:USAELVN:USA | Stock | 1 | 1,062 | -5.87% | 8.63% | 10.12% | 25.95% | -1.90% | -12.49% |
| Immunovant, Inc. | IMVT:USAIMVT:USA | Stock | 1 | 2,975 | -5.92% | 3.55% | 9.72% | 13.35% | -23.12% | -42.79% |
| Celcuity, Inc. | CELC:USACELC:USA | Stock | 1 | 521 | 0.22% | 2.84% | 9.71% | 41.33% | 27.00% | -22.45% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,253 | 89,298,373 | -0.43% | 0.29% | 3.35% | 15.74% | 7.65% | 12.48% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 615 | 2,906,508 | -2.40% | -0.38% | -0.59% | 2.30% | 1.01% | -13.53% |
* Colors indicate performance relative to the benchmark.